Overview

Research on Risk Factors and Interventions of Polycystic Ovary Syndrome Complicated With Depression and Anxiety

Status:
Recruiting

Trial end date:
2024-12-31

Target enrollment:
0

Participant gender:
Female

Summary

The current study intends to establish a prediction method and evaluation system for polycystic ovary syndrome (PCOS) complicated with affective disorder, such as depression and anxiety, through the epidemiological investigation. Randomized controlled studies on the efficacy of various intervention methods should be carried out to develop early intervention measures and methods in order to reduce the harm of psychological disorders, to facilitate the mental health of PCOS patients, and thus to improve the quality of life.

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Fudan University

Treatments:

Contraceptive Agents
Contraceptives, Oral
Contraceptives, Oral, Combined
Drospirenone
Drospirenone and ethinyl estradiol combination
Ethinyl Estradiol
Metformin

Criteria

Inclusion Criteria:

- At least two of the following three criteria were met: clinical and/or biochemical
signs of hyperandrogenism, oligo- and/or anovulation, and polycystic ovary on
ultrasonography,

Exclusion Criteria:

- Any related diseases, such as adrenal congenital hyperplasia, Cushing's syndrome,
androgen-secreting tumors, Hashimoto's thyroiditis, hyperthyroidism or hypothyroidism